Last reviewed · How we verify
NCT04579822
Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy
trial testing influenza vaccine in Pregnancy Related in 300,000 participants. Status unknown.
31 October 2021
Quick facts
| Lead sponsor | Sungkyunkwan University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300,000 |
| Start date | 1 October 2020 |
| Primary completion | 31 October 2021 |
| Estimated completion | 31 December 2022 |
Drugs / interventions tested
- influenza vaccine — full drug profile →
Conditions studied
- Pregnancy Related — all drugs for Pregnancy Related →
- Influenza Virus Vaccine Adverse Reaction — all drugs for Influenza Virus Vaccine Adverse Reaction →
Sponsor
Sungkyunkwan University
Who can join
Adults 20 to 44, female only, with Pregnancy Related or Influenza Virus Vaccine Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a nationwide cohort study to assess maternal and fetal outcomes following vaccination with a quadrivalent influenza vaccine (QIV) during pregnancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04579822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of influenza vaccine
Trials testing the same drug.
- NCT06091410 — Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines · Phase 4 · unknown
- NCT04091880 — Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine · Phase 4 · completed
- NCT03323112 — Immune Responses in Health Care Personnel · recruiting
- NCT03572491 — Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine · Phase 3 · completed
Other recruiting trials for Pregnancy Related
Currently open trials in the same condition.
- NCT05909761 — Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregn · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
- NCT07518550 — Maternal and Fetal Electrocardiograms Separation Algorithm · NA · recruiting
- NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting
Other Sungkyunkwan University trials
Trials by the same sponsor.
- NCT07156955 — Proprioceptive Error Correction for Post-Stroke Upper Limb Rehabilitation · NA · recruiting
- NCT04551248 — Post-marketing Safety Evaluation of Pneumococcal Vaccines Among Children and Elderly Adults. · unknown
- NCT04856436 — Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy · completed
- NCT04115410 — PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study · unknown
- NCT04115423 — A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04579822 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sungkyunkwan University
- Last refreshed: 8 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04579822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing